OBJECTIVE: To determine the prevalence and spectrum of use of @entity34 ( @entity34 ) by @entity1 with @entity1726 and to determine whether use of @entity34 correlates with @entity6100 -specific characteristics. METHODS: The authors administered a structured questionnaire, by interview, regarding the use of @entity34 to 201 @entity1 with @entity1726 . Demographic, social, and disease-specific characteristics were recorded for all @entity1 . RESULTS: Eighty-one @entity1 (40%) used at least one @entity34 . @entity2221 and herbs, massage, and acupuncture were most common. Users of @entity34 were younger (p = 0.0021) and had a younger age at onset of @entity1726 (p = 0.0011) than nonusers of @entity34 . There was no correlation with sex or race. @entity1 who used @entity34 had a higher income (p = 0.038) and education level (p = 0.006) than did nonusers of @entity34 . There was no association between the use of @entity34 and the Hoehn and Yahr score, duration of @entity1726 , duration of treatment with levodopa, surgery for @entity1726 , and presence of fluctuations. CONCLUSIONS: The use of @entity34 is common in @entity1 with @entity1726 . The age at onset of @entity1726 is the most potent predictor of @entity34 use. There is no association between the use of @entity34 and the severity of @entity1726 . The widespread and largely unexamined use of @entity34 for @entity1726 requires more attention. This should be directed at testing their safety and efficacy and improving physician and @entity1 knowledge about the potential benefits, costs, limitations, and risks of @entity34 .

The use of alternative therapies by XXXX with Parkinson's disease.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity6100 :: ('OMIM:300082', 'Disease') :: ['demographic, social, or disease'] @entity1726 :: ('OMIM:168600', 'Disease') :: ['PD'] @entity2221 :: ('CHEBI:33229', 'Chemical') :: ['Vitamins'] @entity34 :: ('MESH:D016609', 'Disease') :: ['alternative therapy', 'AT']
@entity1 :: (9606,Species) :: ['patients']
